Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001181556-25-000006

Director acquired 1,211 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LEVIN ARTHUR A Director 2025-09-30 Option exercise +1,211 3,631 D
Derivatives
LEVIN ARTHUR A Director 2025-09-30 Option exercise · Restricted Stock Units −1,211 1,211 D
Loading xslF345X05/form4-10012025_081019.xml…